In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-
risk prostate cancer (PC), however there is discordance amongst large AS cohort studies …

Context Despite support for active surveillance (AS) as a first treatment choice for men with
low-risk prostate cancer (PC), this strategy is largely underutilised. Objective To …

Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …

Background Active surveillance (AS) has been proposed as an effective strategy to reduce
overtreatment among men with lower risk prostate cancers. However, historical rates of …

Purpose: While major prostate cancer active surveillance programs recommend repeat
testing such as prostate specific antigen and prostate biopsy, to our knowledge compliance …

Purpose: To our knowledge factors affecting the adoption of noncurative initial management
in the United States for low risk prostate cancer on a population based level are unknown …

Answer questions and earn CME/CNE Since the dissemination of prostate‐specific antigen
screening, most men with prostate cancer are now diagnosed with localized, low‐risk …

Objectives To ascertain the treatment trends and patterns of care, for men with prostate
cancer on active surveillance (AS) in V ictoria, A ustralia. Patients and Methods De …

Purpose The aim of this study is to describe the trends and factors that influence the initial
treatment of men with localized prostate cancer (PC) in the United States between 2004 and …

Context Disease-specific registries that enroll a considerable number of patients play a
major role in prostate cancer (PCa) research. Objective To evaluate available registries …